In our November issue of Pharmaceutical Executive FEATURES
Cover Story Pharm Exec's Pipeline Report 2018 Josh Baxt
Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods—and the realization that failures have their place in shaping the pipeline of tomorrow
From the Editor No Overnight Successes Lisa Henderson
Our annual look at the drug industry's pipeline—the progress and the setbacks—puts my thoughts on those people driving new science behind the scenes in pharmaceutical research.
Data Protection When HIPAA Doesn't Apply Jennifer S. Geetter, Shelby Buettner
Outlining the common data transactions between life sciences companies and the HIPAA-regulated stakeholders they deal with daily—and steps pharma can take to secure and protect its own data.
ALSO IN THIS ISSUE Taiwan's Biotech Boom Michelle Maskaly
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups …Read more